The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 175.00
Bid: 170.00
Ask: 180.00
Change: -7.50 (-4.11%)
Spread: 10.00 (5.882%)
Open: 182.50
High: 182.50
Low: 172.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Dealings

11 Oct 2023 07:00

RNS Number : 6849P
Synectics PLC
11 October 2023

RNS

11 October 2023

Synectics plc

("Synectics" or the "Company")

Director/PDMR dealings

Synectics plc (AIM: SNX), a leader in advanced security and surveillance systems, has been notified that on 9 and 10 October 2023, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 13,814 (3,955 and 9,859 respectively) ordinary shares of 20 pence each in the Company ("Ordinary Shares") at an average price of £1.22137 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2023.

Under the terms of the ESAP, participating members, including employees, an Executive Director of the Company and a PDMR, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of Ordinary Shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per Ordinary Share at the beginning of the Period which was £1.15.

As a result of this purchase, the Company has been notified that the following Executive Director and a PDMR have acquired the following interests in Ordinary Shares:

Name

Position

Status

Number of Ordinary Shares purchased by the Trustee

Paul Webb

Chief Executive

Executive Director

782

David Gavin

Divisional Director

PDMR

782

Following these purchases, the interests of Messrs Webb and Gavin in the Ordinary Shares are as follows:

Name

Number of Ordinary Shares Held

Interest in Ordinary Shares in Share Schemes

Resultant Total Interest

% of Issued Share Capital

Paul Webb

57,115

515,079

572,194

3.22

David Gavin

0

60,782

60,782

0.34

For further information, please contact:

Synectics plc

Claire Stewart, Company Secretary

email: info@synecticsplc.com

Tel: +44 (0) 114 280 2828

www.synecticsplc.com

Shore Capital

Tom Griffiths / David Coaten

Tel: +44 (0) 20 7408 4090

Vigo Consulting

Jeremy Garcia / Fiona Hetherington

synectics@vigoconsulting.com

Tel: +44 (0) 20 7390 0230

About Synectics

Synectics plc (AIM: SNX) is a leader in advanced security and surveillance systems that help protect people, property, communities, and assets around the world.

The Company's expertise is in providing solutions for specific markets where security and surveillance are critical to operations. These include gaming, oil and gas, public space, transportation, and critical infrastructure.

Synectics has deep industry experience in these markets and works closely with customers to deliver solutions that are tailored to meet their needs. Technical excellence, combined with decades of experience and long-standing customer relationships, provides fundamental differentiation from mainstream suppliers and makes the Company a stand out in its field.

Find out more at www.synecticsplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQBLFFXBLBFBL
Date   Source Headline
20th Apr 202212:05 pmRNSResult of AGM
20th Apr 20227:00 amRNSAGM Statement
4th Apr 202210:47 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSPosting of Accounts and Notice of AGM
8th Mar 20227:00 amRNSLong Term Infrastructure Contract
4th Mar 20227:00 amRNSAvailability of Annual Report and Accounts
22nd Feb 20227:00 amRNSFinal Results
16th Feb 20227:36 amRNSInvestor Presentation
2nd Feb 20227:00 amRNSNotification of Final Results
14th Dec 20217:00 amRNSContract for New Buses in Northern Ireland
8th Dec 20217:00 amRNSTrading Update
3rd Nov 20217:00 amRNSNew Casino Projects in North America
28th Oct 20217:00 amRNSMajor Project for West Midlands Police
1st Oct 20212:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSContract Award for New Refinery Project
13th Jul 20217:00 amRNSHalf-year Report
14th Jun 20217:00 amRNSTrading Update
2nd Jun 20217:00 amRNSDirector/PDMR Shareholding
28th May 20217:00 amRNSDirector/PDMR Shareholding
11th May 20217:00 amRNSHolding(s) in Company
27th Apr 202111:22 amRNSResult of AGM
27th Apr 20217:00 amRNSBusiness Update
23rd Apr 20214:23 pmRNSHolding(s) in Company
7th Apr 20211:08 pmRNSDirector/PDMR Shareholding
7th Apr 20217:00 amRNSSynectics secures major City of London project
31st Mar 20217:00 amRNSHolding(s) in Company
23rd Mar 20217:00 amRNSPosting of Accounts and Notice of AGM
17th Mar 20217:00 amRNSDirector’s/PCA’s Interest in Shares
4th Mar 20217:00 amRNSPDMR’s Interest in Shares
2nd Mar 20217:00 amRNSFinal Results
17th Feb 20217:00 amRNSFurther contract wins in Irish bus market
10th Feb 20217:00 amRNSLetter of Intent and Notification of Results Date
7th Jan 20217:00 amRNSSynectics’ S-Bahn project goes live
15th Dec 20207:00 amRNSTrading Update
1st Dec 20207:00 amRNSSynectics appoints Dr Kerstin Wendt
26th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20207:36 amRNSDirector/PDMR Shareholding
18th Nov 202011:53 amRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSContract Win
2nd Oct 202011:02 amRNSDirector/PDMR dealings
29th Sep 20207:00 amRNSTrading Update
12th Aug 20207:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirectors' / PDMRs' Interests in Shares
30th Jul 20202:03 pmRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSContract Wins for 'next generation' Irish Buses
27th Jul 20204:40 pmRNSSecond Price Monitoring Extn
27th Jul 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20208:22 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.